| KYOWA KIRIN CO. LTD. |
| Japan |
| Gesundheit |
| JP3256000005 / 858523 |
| KY4 (Frankfurt) |
| FRA:KY4, ETR:KY4, KY4:GR |
| Nikkei225 |
| https://www.kyowakirin.co.. |
|
Kyowa Kirin Co., Ltd. is a prominent pharmaceutical company based in Japan, specializing in the research, development, and commercialization of innovative medical treatments. With a strong focus on life sciences, the company is dedicated to addressin..
>Volltext.. |
| 7319.99 Mio. EUR |
| 6010.45 Mio. EUR |
| 2919.02 Mio. EUR |
| 872.85 Mio. EUR |
| 448.14 Mio. EUR |
| 0.86 EUR |
| 122.33 Mio. EUR |
| 1460.52 Mio. EUR |
| 760.96 Mio. EUR |
| 1.45 |
| -1.82% |
| 93.54% |
| 0.35 EUR |
| 2.72% |
| 2.91% |
| 29.06.26 - 0.18918201€ 29.12.25 - 0.163275€ >weitere anzeigen... |
| - |
| KYOWA KIRIN |
| 02.11.26 |
|
||||
|
||||
|
||||
|
||||
|